Drugs / Paclitaxel-binding albumin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04060459 | Oct 2018 → Oct 2020 | urinary bladder cancer | Third Military Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Paclitaxel-binding albumin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04060459 ↗ |
| Route | Intravenous | “Paclitaxel-binding albumin 260 mg/m2，d1，ivgtt” NCT04060459 ↗ |